Mr. Lior Buchman (CPA) joins HIL’s Board of Directors Mr. Buchman has over 20 years of experience in senior corporate financing, mergers & acquisitions, investor relations,
HIL is awarded a European Union R&D grant under Horizon 2020 Horizon 2020 is the EU’s framework programme for research and innovation. According to the
HIL named one of 10 Coolest Biotech Companies in Jerusalem ISRAL21c, together with JLM-BioCity today shared their thoughts on the Coolest Biotech Companies in Jerusalem.
HIL Applied Medical and University of Nevada announce collaboration Win-win-win: Nevada Terawatt Facility hosts research, Israeli-based company invests in equipment and proton-therapy advances for cancer
HIL at the 3rd China-Israel Investment Summit, in Hong-Kong and Zhuhai Taking place this week for the third consecutive year, the China-Israel Investment Summit is
HIL North America to present at CiMED 2017, in California CiMED (the California-Israel Medical Technology Summit) connects Israeli MedTech companies to the Silicon Valley health